Jeremy Grantham's CL Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 40,605 shares of Colgate-Palmolive Company (CL) worth $3.25 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Jeremy Grantham has maintained a long-term strategic position in CL, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2014, adding 783,055 shares. Largest reduction occurred in Q2 2015, reducing 2.87 M shares.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's Colgate-Palmolive Company (CL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Colgate-Palmolive Company (CL) Trades by Jeremy Grantham
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +12.68 M | Add 0.00% | 12.68 M | $57.29 |
| Q3 2013 | -1.61 M | Reduce 12.69% | 11.07 M | $59.30 |
| Q4 2013 | -769,610 | Reduce 6.95% | 10.3 M | $65.21 |
| Q1 2014 | -943,880 | Reduce 9.16% | 9.36 M | $64.87 |
| Q2 2014 | -1.4 M | Reduce 14.98% | 7.96 M | $68.18 |
| Q3 2014 | -64,620 | Reduce 0.81% | 7.89 M | $65.22 |
| Q4 2014 | +783,055 | Add 9.92% | 8.68 M | $69.19 |
| Q1 2015 | +283,910 | Add 3.27% | 8.96 M | $69.34 |
| Q2 2015 | -2.87 M | Reduce 32.00% | 6.09 M | $65.41 |
| Q3 2015 | -1.37 M | Reduce 22.50% | 4.72 M | $63.46 |
| Q4 2015 | -2.06 M | Reduce 43.61% | 2.66 M | $66.62 |
| Q1 2016 | -378,572 | Reduce 14.21% | 2.28 M | $70.65 |
| Q2 2016 | +475,943 | Add 20.83% | 2.76 M | $73.20 |
| Q3 2016 | -637,932 | Reduce 23.11% | 2.12 M | $74.14 |
| Q4 2016 | -1.09 M | Reduce 51.43% | 1.03 M | $65.44 |
| Q1 2017 | -984,224 | Reduce 95.47% | 46,719 | $73.18 |
| Q2 2017 | -46,719 | Sold Out | 46,719 | $0.00 |
| Q3 2017 | +67,846 | New Buy | 67,846 | $72.86 |
| Q4 2017 | -50,949 | Reduce 75.10% | 16,897 | $75.46 |
| Q1 2018 | +580,159 | Add 3433.50% | 597,056 | $71.68 |
| Q2 2018 | +4,852 | Add 0.81% | 601,908 | $64.81 |
| Q3 2018 | -330,238 | Reduce 54.87% | 271,670 | $66.95 |
| Q4 2018 | -271,670 | Sold Out | 271,670 | $0.00 |
| Q2 2019 | +133,882 | New Buy | 133,882 | $71.67 |
| Q3 2019 | -17,900 | Reduce 13.37% | 115,982 | $73.51 |
| Q4 2019 | -48,935 | Reduce 42.19% | 67,047 | $68.85 |
| Q1 2020 | +11,471 | Add 17.11% | 78,518 | $66.35 |
| Q2 2020 | -6,200 | Reduce 7.90% | 72,318 | $73.26 |
| Q4 2020 | -45,998 | Reduce 63.61% | 26,320 | $85.52 |
| Q1 2021 | +45,700 | Add 173.63% | 72,020 | $78.83 |
| Q2 2021 | +98,615 | Add 136.93% | 170,635 | $81.35 |
| Q3 2021 | +29,436 | Add 17.25% | 200,071 | $75.58 |
| Q4 2021 | -41,464 | Reduce 20.72% | 158,607 | $85.34 |
| Q1 2022 | +8,668 | Add 5.47% | 167,275 | $75.83 |
| Q2 2022 | -167,275 | Sold Out | 167,275 | $0.00 |
| Q2 2023 | +67,143 | New Buy | 67,143 | $77.04 |
| Q3 2023 | -38,663 | Reduce 57.58% | 28,480 | $71.11 |
| Q4 2023 | -28,480 | Sold Out | 28,480 | $0.00 |
| Q2 2024 | +10,769 | New Buy | 10,769 | $97.04 |
| Q3 2024 | +1,413 | Add 13.12% | 12,182 | $103.81 |
| Q4 2024 | +495 | Add 4.06% | 12,677 | $90.91 |
| Q1 2025 | +6,952 | Add 54.84% | 19,629 | $93.70 |
| Q2 2025 | -6,820 | Reduce 34.74% | 12,809 | $90.90 |
| Q3 2025 | +27,796 | Add 217.00% | 40,605 | $79.94 |
Jeremy Grantham's Colgate-Palmolive Company Investment FAQs
Jeremy Grantham first purchased Colgate-Palmolive Company (CL) in Q2 2013, acquiring 12,683,876 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held Colgate-Palmolive Company (CL) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham's largest addition to Colgate-Palmolive Company (CL) was in Q2 2013, adding 12,683,876 shares worth $726.66 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 40,605 shares of Colgate-Palmolive Company (CL), valued at approximately $3.25 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Colgate-Palmolive Company (CL) represents approximately 0.01% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham's peak holding in Colgate-Palmolive Company (CL) was 12,683,876 shares, as reported at the end of Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.